4.7 Article

Plant-derived Ren's oligopeptide has antiviral effects on influenza virus and SARS-CoV-2

Related references

Note: Only part of the references are listed.
Review Chemistry, Medicinal

A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19

Robert L. Chapman et al.

Summary: The ongoing COVID-19 pandemic has resulted in nearly 247 million cases and over 5 million deaths worldwide as of November 2021. Natural constituents found in traditional herbal medicines and foods have shown activity against SARS-CoV-2 by affecting inflammation, cell signaling pathways, and viral targets. Further research is needed to explore their potential in the treatment of COVID-19 through rational drug design and clinical trials.

MEDICINAL CHEMISTRY RESEARCH (2022)

Review Virology

Covid-19 vaccines and variants of concern: A review

Ikbel Hadj Hassine

Summary: Since the outbreak of Covid-19 in December 2019, there have been over 242 million confirmed cases and nearly 5 million deaths worldwide. Nine Covid-19 vaccine candidates based on the original Wuhan-Hu-1 strain have efficacy over 50%, but face challenges from emerging variants and rare adverse events. Additional effective vaccines are still needed to meet global demand, with promising candidates progressing to clinical studies.

REVIEWS IN MEDICAL VIROLOGY (2022)

Article Pharmacology & Pharmacy

Nirmatrelvir Plus Ritonavir: First Approval

Yvette N. Lamb

Summary: Nirmatrelvir plus ritonavir is a medication developed for the treatment and post-exposure prophylaxis of COVID-19. It received authorization in the UK and EU for use in adults at high risk for severe COVID-19. Nirmatrelvir is an inhibitor of SARS-CoV-2 main protease, while ritonavir is a protease inhibitor and CYP3A inhibitor.

DRUGS (2022)

Letter Surgery

SARS-CoV-2 and Influenza A virus: Dual diagnostics and vaccines

AbdulRahman A. Saied et al.

INTERNATIONAL JOURNAL OF SURGERY (2022)

Article Biology

The natural antiviral and immune stimulant effects of Allium cepa essential oil onion extract against virulent Newcastle disease virus

Mohamed Lebdah et al.

Summary: The study suggests that Allium cepa essential oils (ACEO) have antiviral and immune-enhancing effects against Newcastle disease virus in broilers, reducing mortality and viral shedding while boosting immune response.

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2022)

Review Cell Biology

Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids

Seidu A. Richard

Summary: Licorice extract, consisting primarily of glycyrrhizic (GL) and glycyrrhetinic acid (GA), acts as a potent antioxidant, anti-inflammatory, antiviral, antitumor, and immunoregulatory agent. It exhibits strong activities against various viruses and inflammatory responses through modulation of cytokines, enzymes, and transcription factors. Moreover, GA shows therapeutic potential in human enterovirus 71, a common virus associated with hand, foot, and mouth disease.

MEDIATORS OF INFLAMMATION (2021)

Article Biochemistry & Molecular Biology

Antioxidant and Antiproliferative Activity of the Ethanolic Extract of Equisetum myriochaetum and Molecular Docking of Its Main Metabolites (Apigenin, Kaempferol, and Quercetin) on β-Tubulin

Fabian Olazaran-Santibanez et al.

Summary: Equisetum myriochaetum, a semi-aquatic plant commonly used in traditional medicine as a diuretic agent, contains the flavonoid kaempferol which is known for its antiproliferative properties. The ethanolic extract of E. myriochaetum showed antioxidative activity and antiproliferative effects against SiHa cancer cells. The molecular docking analysis of apigenin, kaempferol, and quercetin on beta-tubulin active site suggested a potential mechanism for their action.

MOLECULES (2021)

Review Pharmacology & Pharmacy

A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection

Juwairiah Remali et al.

Summary: The article discusses the feasibility of using various herbal plants to treat coronavirus infection and their mechanisms of action. It is hoped that this compilation will help researchers and clinicians identify appropriate antiviral drugs from plants to combat COVID-19 and ultimately save millions of affected human lives.

FRONTIERS IN PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

Mohd Imran et al.

Summary: Molnupiravir, developed initially for influenza treatment, has shown promising activity against various viruses, including SARS-CoV-2. With good safety profile and oral bioavailability, it is currently in development for treating COVID-19 and expected to be available in an oral dosage form in 2022. Patent data suggests potential combinations with other drugs to enhance efficacy.

MOLECULES (2021)

Review Virology

A brief review of influenza virus infection

Mostafa Javanian et al.

Summary: Influenza is an acute viral respiratory infection that affects all age groups and is associated with high mortality. Vaccination is the most effective method for prevention, but antiviral drugs are also available for treatment.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Infectious Diseases

Molnupiravir-A Novel Oral Anti-SARS-CoV-2 Agent

Ching-Chi Lee et al.

Summary: Molnupiravir, an oral antiviral agent, has shown significant efficacy in treating COVID-19. Clinical trials have demonstrated its potential importance in treating COVID-19 patients and preventing virus transmission.

ANTIBIOTICS-BASEL (2021)

Review Medicine, General & Internal

Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review

Windi Fresha Qomara et al.

Summary: This systematic review summarizes the clinical effectiveness and safety of three antiviral drugs, remdesivir, favipiravir, and lopinavir/ritonavir, in the management of COVID-19. Remdesivir shows potential benefits in improving clinical outcomes for hospitalized COVID-19 patients, while favipiravir and lopinavir/ritonavir have varying effects on clinical parameters. Further well-designed clinical trials are needed to confirm these findings.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Article Pharmacology & Pharmacy

Transdermal Film Loaded with Garlic Oil-Acyclovir Nanoemulsion to Overcome Barriers for Its Use in Alleviating Cold Sore Conditions

Alshaimaa M. Almehmady et al.

Summary: The study formulated an ACV-GO self-nanoemulsifying drug delivery system (ACV-GO-SNEDDS) and demonstrated its potential in enhancing the permeability and bioavailability of ACV in transdermal films.

PHARMACEUTICS (2021)

Review Public, Environmental & Occupational Health

Egypt's COVID-19 Recent Happenings and Perspectives: A Mini-Review

AbdulRahman A. Saied et al.

Summary: The article discusses the impact of the COVID-19 pandemic globally, vaccine distribution, and the epidemiological data in different countries, while highlighting the threat of SARS-CoV-2 variants and mutations to public health.

FRONTIERS IN PUBLIC HEALTH (2021)

Review Medicine, General & Internal

Comparison of Antiviral Agents for Seasonal Influenza Outcomes in Healthy Adults and Children A Systematic Review and Network Meta-analysis

Jen-Wei Liu et al.

Summary: This study compared the efficacy and safety of neuraminidase inhibitors and the endonuclease inhibitor for the treatment of seasonal influenza among healthy adults and children. The results showed that zanamivir was associated with the shortest time to alleviation of influenza symptoms, while baloxavir was associated with reduced rate of influenza-related complications.

JAMA NETWORK OPEN (2021)

Article Chemistry, Medicinal

Favipiravir and COVID-19: A Simplified Summary

Morteza Ghasemnejad-Berenji et al.

Summary: This review summarizes the clinical trials studying the efficacy and safety of favipiravir in patients with COVID-19, highlighting it as a potential treatment option for the novel coronavirus infection.

DRUG RESEARCH (2021)

Review Public, Environmental & Occupational Health

Remdesivir and its antiviral activity against COVID-19: A systematic review

Andri Frediansyah et al.

Summary: Remdesivir exhibits potent antiviral activities against SARS-CoV-2 and has shown efficacy in treating COVID-19 patients in clinical practice, but further efficacy assessments in clinical trials are needed.

CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)

Review Chemistry, Medicinal

Natural products as home-based prophylactic and symptom management agents in the setting ofCOVID-19

Sai Manohar Thota et al.

PHYTOTHERAPY RESEARCH (2020)

Review Immunology

Influenza Virus: Dealing with a Drifting and Shifting Pathogen

Hyunsuh Kim et al.

VIRAL IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

The inhibition effect of garlic-derived compounds on human immunodeficiency virus type 1 and saquinavir

Faik Gokalp

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2018)

Article Agriculture, Multidisciplinary

Anti-influenza A Virus Activity of Dendrobine and Its Mechanism of Action

Richan Li et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)

Review Infectious Diseases

Peramivir injection in the treatment of acute influenza: a review of the literature

Ashley Wester et al.

INFECTION AND DRUG RESISTANCE (2016)

Article Biochemistry & Molecular Biology

Anomeric selectivity and influenza A virus inhibition study on methoxylated analogues of Pentagalloylglucose

Shaikh Qurat-ul-Ain et al.

CARBOHYDRATE RESEARCH (2015)

Article Biochemistry & Molecular Biology

Gingerols and shogaols: Important nutraceutical principles from ginger

Ruchi Badoni Semwal et al.

PHYTOCHEMISTRY (2015)

Review Pharmacology & Pharmacy

Traditional Chinese herbal medicine as a source of molecules with antiviral activity

Ting Li et al.

ANTIVIRAL RESEARCH (2013)

Review Allergy

Traditional Chinese Medicine and Immune Regulation

Hong-Di Ma et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)

Article Integrative & Complementary Medicine

Antiviral Protein of Momordica charantia L. Inhibits Different Subtypes of Influenza A

Viroj Pongthanapisith et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)

Article Virology

Antivirals and resistance: influenza virus

Michael G. Ison

CURRENT OPINION IN VIROLOGY (2011)

Review Medicine, Research & Experimental

Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy

M. Puri et al.

CURRENT MOLECULAR MEDICINE (2009)